LOGIN  |  REGISTER
Viking Therapeutics
Cue Biopharma

Community Health Systems to Webcast First Quarter 2025 Conference Call

April 09, 2025 | Last Trade: US$3.33 0.08 -2.35

FRANKLIN, Tenn. / Apr 09, 2025 / Business Wire / Community Health Systems, Inc. (NYSE: CYH) today announced that it will webcast its first quarter 2025 conference call.

The Company will issue a press release announcing its results on Wednesday, April 23, 2025, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time, on Thursday, April 24, 2025. During this call, Community Health Systems will review the Company’s financial and operating results for the first quarter ended March 31, 2025.

A live webcast of the conference call will be available online at https://www.chs.net/investor-relations/investor-tools/webcasts/. An online replay will follow shortly after the call and continue for approximately 30 days.

You can join the live call by dialing 1-833-630-1961 (domestic) or 1-412-317-1842 (international). Once connected, request to be joined into the Community Health Systems, Inc. call. A telephonic replay of the conference call will be available through May 1, 2025, by dialing 1-877-344-7529 and entering the confirmation number, 8502644.

About Community Health Systems, Inc.

Community Health Systems, Inc. is one of the nation’s largest healthcare companies. The Company’s affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 36 distinct markets across 14 states. The Company’s subsidiaries own or lease 72 affiliated hospitals with more than 10,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.” The Company’s headquarters are located in Franklin, Tennessee, a suburb south of Nashville. More information about the Company can be found on its website at www.chs.net.

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page